BMC COAXIAL INJECTABLE CATHETER, MODEL CIC 38/145 AND CIC 35/145— 510(k) K014075

Substantially Equivalent

Baylis Medical Co., Inc.

FDA 510(k) clearance K014075 for BMC COAXIAL INJECTABLE CATHETER, MODEL CIC 38/145 AND CIC 35/145, Substantially Equivalent on 2002-03-07. Applicant: Baylis Medical Co., Inc..

Clearance details

Applicant: Baylis Medical Co., Inc.
Product code: Code DQX
Advisory panel: Cardiovascular
Date received: 2001-12-11
Decision date: 2002-03-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mississauga, Ontario, CA

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQX

product code DQX

Death: 298
Injury: 4,385
Malfunction: 7,203
Other: 5
Total: 11,891

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.